Allulose for attenuation of blood glucose levels after meal in healthy huma
- Conditions
- Healthy Human
- Registration Number
- JPRN-UMIN000039586
- Lead Sponsor
- Matsutani Chemical Industry Co. Ltd.
- Brief Summary
The study collected all D-allulose related studies from various databases. A forest plot of the comparison between an allulose intake group and the control group showed both 5g and 10g intake groups have the significantly smaller area under the curve of postprandial blood glucose levels. It means that D-Allulose attenuates postprandial blood glucose concentrations in healthy humans.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 290
Not provided
The study is a review or a case study or doesn't report any experiment. The study with control or placebo group can't be found, so that there is no comparison can be done. The part of study patients has certain medical conditions and could not obtain data with only healthy patients. The part of study intervention is allulose and could not obtain data with only allulose intervention. The study doesn't indicate the level of allulose intake. The study doesn't measure total AUC of blood glucose levels for 2 hours or could not obtain a data for 2 hours from authors' group.
Study & Design
- Study Type
- Others,meta-analysis etc
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Does allulose intake (<= 10g) attenuate postprandial blood glucose levels in healthy human?
- Secondary Outcome Measures
Name Time Method Does lower intake of allulose (<= 5g) attenuate postprandial blood glucose levels in healthy human? In other words, is there any difference in two different doses?